Form 8-K · Item 4.02 · Non-reliance

Goldenwell Biotech, Inc.: non-reliance on previously issued financial statements

Goldenwell Biotech, Inc. reported in a Form 8-K filed May 27, 2026, that on May 19, 2025, its independent accountant notified it that previously issued financial statements should no longer be relied upon: the financial statements filed with the March 31, 2025 Form 10-Q; the June 30, 2025 Form 10-Q; the September 30, 2025 Form 10-Q.

In the filing's words

On May 19, 2025, the Company’s independent registered public accounting firm, Michael Gillsepie & Associates, PLLC (“Gillespie & Associates”), notified the Company that the Company did not follow US GAAP
the financial statements filed with the March 31, 2025 Form 10-Q, the June 30, 2025 Form 10-Q, and the September 30, 2025 Form 10-Q should no longer be relied upon insofar as they relate to the $9,840 of legal expenses accrued between May 21, 2024 and September 23, 2025.
An authorized officer of the Company communicated with Gillespie & Associates regarding the matters disclosed in the filing pursuant to this Item 4.02(b).

Verbatim from sec.gov, Item 4.02 (Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review). We quote the filing; we do not characterize it.

CompanyGoldenwell Biotech, Inc.
TickerGWLL
Form and item8-K, Item 4.02
Filed with the SECMay 27, 2026
Statements no longer relied upon
  • the financial statements filed with the March 31, 2025 Form 10-Q
  • the June 30, 2025 Form 10-Q
  • the September 30, 2025 Form 10-Q
Concluded byauditor notice
Date of the conclusionMay 19, 2025
Discussed with the accountantnot stated
Accession number0001477932-26-003440
SEC CIK0001800373

Goldenwell Biotech, Inc. reported under Form 8-K Item 4.02 (Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review), filed May 27, 2026. The filing's own words are quoted above.

Sources

  • sec.gov · SEC filing, Form 8-K, Item 4.02 · accessed 2026-10-24

Goldenwell Biotech, Inc.'s other filings on auditors and restatements

More: all non-reliance and restatements · Something wrong? Send a correction with the primary source.